Point-of-Care Diagnostics Market By Products (Infectious Disease Testing, Glucose Monitoring, Hematology Testing, Pregnancy and Fertility Testing, Urinalysis Testing, Cardiometabolic Monitoring, Tumors or Cancer Marker Testing, Coagulation Monitoring, Cholesterol Testing, Drugs of Abuse Testing), Prescription Mode (Prescription-based Point-of-Care Diagnostics, Over-the-Counter-based Point-of-Care Diagnostics), End-users (Hospitals, Clinics/Physician Office Laboratory, Home Care, Ambulatory Care), and Regions (North America, Europe, Asia Pacific, Rest of the World): Global Forecast up to 2025

Global Point-of-Care Diagnostics Market By Products (Infectious Disease Testing, Glucose Monitoring, Hematology Testing, Pregnancy and Fertility Testing, Urinalysis Testing, Cardiometabolic Monitoring, Tumors or Cancer Marker Testing, Coagulation Monitoring, Cholesterol Testing, Drugs of Abuse Testing), Prescription Mode (Prescription-based Point-of-Care Diagnostics, Over-the-Counter-based Point-of-Care Diagnostics), End-users (Hospitals, Clinics/Physician Office Laboratory, Home Care, Ambulatory Care), and Regions (North America, Europe, Asia Pacific, Rest of the World): Global Forecast up to 2025
This market research report includes a detailed segmentation of the global point-of-care diagnostics market by products (infectious disease testing, glucose monitoring, hematology testing, pregnancy and fertility testing, urinalysis testing, cardiometabolic monitoring, tumors or cancer marker testing, coagulation monitoring, cholesterol testing, drugs of abuse testing, and others), by prescription mode (prescription-based point-of-care diagnostics and over-the-counter-based point-of-care diagnostics), by end-users (hospitals, clinics/physician office laboratory, home care, and ambulatory care), and by regions (North America, Europe, Asia Pacific, and Rest of the World).
Overview of the Global Point-of-Care Diagnostics Market Research:
Infoholics market research report predicts that the global point-of-care diagnostics market will grow at a CAGR of 7.3% during the forecast period 20192025. The market has witnessed steady growth in the past few years, and the advancements in technology with the launch of innovative products have increased the adoption of point-of-care diagnostics products. The market is fueled by the increasing prevalence of infectious diseases, upsurge in the incidence of lifestyle diseases, increasing geriatric population, and rising adoption of the technology in emerging countries.

The market continues to grow as point-of-care diagnostics is one of the most widely used techniques for screening, diagnosis, and making a treatment decision. Key market players are focusing on product approvals, new launches, and targeting end-users perspective. The market generates significant revenue from the key players operating in this field, and few of them include Abbott Laboratories, F. Hoffmann-La Roche, Johnson & Johnson, Danaher Corporation, and Siemens Healthineers Inc. (Siemens AG).
According to analysis, North America accounted for the largest share of the global point-of-care diagnostics market in 2018, and Asia Pacific is expected to grow at a high CAGR during the forecast period. According to a report released by the Centers for Disease Control and Prevention (CDC), in the US alone, more than 100 million adults are now living with diabetes or prediabetes. According to an estimation, in the US, approximately 1,688,780 new cancer cases were diagnosed and 600,920 cancer deaths were reported in 2017. Canada had an estimated 206,200 new cases of cancer and 80,800 deaths from cancer in 2017. Cardiovascular disease (CVD) accounts for approximately 800,000 deaths in the US, and on an average, one person dies from CVD every 40 seconds in the US. Coronary heart disease accounts for the majority of CVD deaths followed by stroke and heart failure. The presence of dominant players in the region, promising reimbursement facilities, availability of hi-tech medical technologies, and growing patient base for lifestyle diseases make North America the dominant shareholder in the market.
By Products:
Infectious Disease Testing (influenza testing, HIV testing, hepatitis testing, tuberculosis testing, sexually transmitted diseases testing, healthcare-associated infections testing, respiratory infections testing, others)
Glucose Monitoring
Hematology Testing
Pregnancy and Fertility Testing
Urinalysis Testing
Cardiometabolic Monitoring
Tumors or Cancer Marker Testing
Coagulation Monitoring
Cholesterol Testing
Drugs of Abuse Testing
Others
Glucose monitoring kits, in terms of point-of-care diagnostics products, held a significant market share in 2018, owing to an increase in the prevalence of diabetes, change in lifestyle, growing elderly population, and increasing demand for disease management. The infectious disease testing segment is expected to grow at a high CAGR during the forecast period 20192025.
By Prescription Mode:
Prescription-based Point-of-Care Diagnostics
Over-the-Counter-based Point-of-Care Diagnostics
The prescription-based diagnostic tests occupied the largest share in 2018 with mid-single-digit CAGR, and over-the-counter-based point-of-care diagnostics is estimated to grow at the highest CAGR during the forecast period.
By End-users:
Hospitals
Clinics/Physician Office Laboratory
Home Care
Ambulatory Care
Others
Growing preference for home or remote monitoring, introduction of portable point-of-care products, and increasing demand for rapid tests among home care users make home care the fastest-growing segment during the forecast period 20192025.
By Regions:
North America
Europe
Asia Pacific
Rest of the World
Based on geography, North America dominated the market in 2018 with a share of over 40% and is expected to maintain this position during the forecast period. Asia Pacific is projected to grow at a high CAGR during the forecast period. The increasing incidence of chronic and lifestyle diseases, booming economy, and increasing health awareness among patients make North America the fastest-growing region during the forecast period.
Global Point-of-Care Diagnostics Market Research Competitive Analysis: The market is growing at a steady rate with a CAGR of 7.3% during the forecast period 20192025. A lot of new players are concentrating on this market to deliver advanced and innovative products. The increasing adoption of point-of-care diagnostics has resulted in increased approvals, new launches, strategic collaborations, acquisitions, and increased funding. For instance, in February 2019, HemoCue received the FDA approval for its HemoCue Hb 801 System that quantitatively measures hemoglobin in capillary or venous whole blood. In June 2019, Abbott launched its Afinion HbA1c Dx assay available for use on the Afinion 2 Analyzer, as well as the Afinion AS100 Analyzer. Afinion HbA1c Dx assay is the first rapid point-of-care test approved by the FDA to aid healthcare professionals in the diagnosis of diabetes. In March 2019, Group K Diagnostics partnered with the US Centers for Disease Control and Prevention to design and evaluate a prototype reverse transcriptase loop-mediated isothermal amplification assay to detect Zika virus RNA at POC.
Key Vendors:
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Johnson & Johnson
Danaher Corporation
Siemens Healthineers Inc. (Siemens AG)
Trinity Biotech plc
Qiagen N.V.
OraSure Technologies Inc.
Instrumentation Laboratory (IL)
Becton Dickinson and Company
Nova Biomedical
Key Competitive Facts:
The market is highly competitive with all the players competing to gain market shares. Intense competition, rapid advancements in technology, frequent changes in government policies, and the prices are key factors that confront the market.
The market is moving strongly toward smart devices that are equipped with mobile healthcare (mH). This smart healthcare option is expected to revolutionize personalized healthcare monitoring and management, thus leading the way for next-generation point-of-care testing.
Benefits The report provides complete details about the sub-segment of the global point-of-care diagnostics market. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical players initiatives, and government initiatives toward the diagnostics segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.
Key Takeaways:
Understanding the potential market opportunity with precise market size and forecast data.
Detailed market analysis focusing on the growth of point-of-care diagnostics industry.
Factors influencing the growth of the point-of-care diagnostics market.
In-depth competitive analysis of dominant and pure-play vendors.
Prediction analysis of the point-of-care diagnostics industry in both developed and developing regions.
Key insights related to major segments of the point-of-care diagnostics market.
Latest market trend analysis impacting the buying behavior of the consumers.
Key Stakeholders:
1Industry Outlook
1.1Industry Overview
1.2Total Addressable Market
1.3Industry Trends
2Report Outline
2.1Report Scope
2.2Report Summary
2.3Research Methodology
2.4Report Assumptions
3Market Snapshot
3.1Market Definition Infoholic Research
3.2Advantages of Point-of-Care Testing
3.3Disadvantages of Point-of-Care Testing
3.4Segmented Addressable Market
3.5Trends in the Point-of-Care Diagnostics Market
3.6Related Markets
3.6.1Molecular Diagnostics
3.6.2Infectious Disease Diagnostics
4Market Outlook
4.1Market Segmentation
4.2PEST Analysis
4.3Porter 5 (Five) Forces
5Market Characteristics
5.1DRO Market Dynamics
5.1.1Drivers
5.1.1.1Increasing prevalence of infectious disease
5.1.1.2Growing incidence of lifestyle disease
5.1.1.3Technological innovations
5.1.1.4Increasing adoption of point-of-care diagnostics
5.1.2Opportunities
5.1.2.1Growth opportunities in emerging markets
5.1.2.2Increasing awareness towards point-of-care diagnostics in developing countries
5.1.3Restraints
5.1.3.1Stringent approval process
5.1.3.2Product recalls
5.1.3.3Unfavorable reimbursement scenario
5.2DRO Impact Analysis
5.3Key Stakeholders
6Product: Market Size and Analysis
6.1Overview
6.2Glucose Monitoring
6.3Infectious Disease Testing
6.3.1Influenza Testing
6.3.2HIV Testing
6.3.3Hepatitis Testing
6.3.4Tuberculosis Testing
6.3.5Sexually Transmitted Diseases Testing
6.3.6Healthcare-associated Infections Testing
6.3.7Respiratory Infections Testing
6.3.8Others
6.4Pregnancy and Fertility Testing
6.5Hematology Testing
6.6Cardiometabolic Monitoring
6.7Urinalysis Testing
6.8Coagulation Monitoring
6.9Tumor or Cancer Marker Testing
6.10Cholesterol Testing
6.11Drugs of Abuse Testing
6.12Others
7Prescription Mode: Market Size and Analysis
7.1Overview
7.2Prescription-based Point-of-Care Diagnostics
7.3Over the Counter-based Point-of-Care Diagnostics
8End-users: Market Size and Analysis
8.1Overview
8.2Hospitals
8.3Clinics/Physician Office Laboratory (POL)
8.4Home Care
8.5Ambulatory Care
8.6Others
9Regions: Market Size and Analysis
9.1Overview
9.2North America
9.2.1Overview
9.2.2US
9.2.3Canada
9.3Europe
9.3.1Overview
9.3.2UK
9.3.3Germany
9.3.4France
9.3.5Spain
9.3.6Italy
9.3.7Others
9.4APAC
9.4.1Overview
9.4.2India
9.4.3China
9.5Rest of the World
10Competitive Landscape
10.1Overview
11Vendors Profile
11.1Abbott Laboratories
11.1.1Overview
11.1.2Business Units
11.1.3Geographic Revenue
11.1.4Business Focus
11.1.5SWOT Analysis
11.1.6Business Strategies
11.2F. Hoffmann-La Roche Ltd.
11.2.1Overview
11.2.2Business Units
11.2.3Geographic Revenue
11.2.4Business Focus
11.2.5SWOT Analysis
11.2.6Business Strategies
11.3Johnson & Johnson
11.3.1Overview
11.3.2Business Units
11.3.3Geographic Revenue
11.3.4Business Focus
11.3.5SWOT Analysis
11.3.6Business Strategies
11.4Danaher Corporation
11.4.1Overview
11.4.2Business Units
11.4.3Geographic Revenue
11.4.4Business Focus
11.4.5SWOT Analysis
11.4.6Business Strategies
11.5Siemens Healthineers Inc. (Siemens AG)
11.5.1Overview
11.5.2Business Units
11.5.3Geographic Revenue
11.5.4Business Focus
11.5.5SWOT Analysis
11.5.6Business Strategies
12Companies to Watch For
12.1Trinity Biotech plc
12.1.1Overview
12.2Qiagen N.V.
12.2.1Overview
12.3BioMerieux S.A.
12.3.1Overview
12.4OraSure Technologies Inc.
12.4.1Overview
12.5Instrumentation Laboratory (A Werfen Company)
12.5.1Overview
12.6Becton Dickinson and Company
12.6.1Overview
12.7Nova Biomedical
12.7.1Overview
Annexure
Abbreviations


List Of Tables



TABLE 1FUNDING SCENARIO19
TABLE 2GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCTS, 20182025 ($MILLION)33
TABLE 3GLOBAL INFECTIOUS DISEASE POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE, 20182025 ($MILLION)36
TABLE 4GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET, BY PRESCRIPTION MODE, 20182025 ($MILLION)57
TABLE 5GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET REVENUE BY REGIONS, 20182025 ($MILLION)64
TABLE 6EUROPEAN POINT-OF-CARE DIAGNOSTICS MARKET, BY COUNTRY, 20182025 ($MILLION)67
TABLE 7GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY VENDOR RANKING, 201879
TABLE 8OTHER PROMINENT VENDORS OF POINT-OF-CARE DIAGNOSTICS MARKET79
TABLE 9ABBOTT LABORATORIES: PRODUCT OFFERINGS81
TABLE 10ABBOTT LABORATORIES: RECENT DEVELOPMENTS82
TABLE 11F. HOFFMANN-LA ROCHE: PRODUCT OFFERINGS90
TABLE 12F. HOFFMANN-LA ROCHE: RECENT DEVELOPMENTS91
TABLE 13JOHNSON & JOHNSON: PRODUCT OFFERINGS98
TABLE 14JOHNSON & JOHNSON: RECENT DEVELOPMENTS98
TABLE 15DANAHER CORPORATION: PRODUCT OFFERINGS106
TABLE 16DANAHER CORPORATION: RECENT DEVELOPMENTS109
TABLE 17SIEMENS HEALTHINEERS INC.: PRODUCT OFFERINGS116
TABLE 18SIEMENS HEALTHINEERS INC.: RECENT DEVELOPMENTS117
TABLE 19TRINITY BIOTECH PLC: SNAPSHOT124
TABLE 20TRINITY BIOTECH PLC: RECENT DEVELOPMENTS125
TABLE 21QIAGEN N.V.: SNAPSHOT125
TABLE 22QIAGEN N.V.: RECENT DEVELOPMENTS126
TABLE 23BIOMERIEUX S.A.: SNAPSHOT131
TABLE 24BIOMERIEUX S.A.: RECENT DEVELOPMENTS132
TABLE 25ORASURE TECHNOLOGIES: SNAPSHOT133
TABLE 26ORASURES TECHNOLOGIES: RECENT DEVELOPMENTS134
TABLE 27INSTRUMENTATION LABORATORY: SNAPSHOT134
TABLE 28INSTRUMENTATION LABORATORY: RECENT DEVELOPMENTS135
TABLE 29BECTON DICKINSON AND COMPANY: SNAPSHOT136
TABLE 30BECTON DICKINSON AND COMPANY: RECENT DEVELOPMENTS137
TABLE 31NOVA BIOMEDICAL: SNAPSHOT139
TABLE 32NOVA BIOMEDICAL: RECENT DEVELOPMENTS139


List Of Figures

Charts

CHART 1RESEARCH METHODOLOGY OF GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET13
CHART 2GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET REVENUE, 20192025 ($MILLION)17
CHART 3SEGMENTATION OF GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET21
CHART 4PEST ANALYSIS OF GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET21
CHART 5PORTER 5 FORCES ON GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET23
CHART 6DRO IMPACT ANALYSIS OF GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET29
CHART 7KEY STAKEHOLDERS31
CHART 8GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY PRODUCT, 2018 V/S 2025 ($)32
CHART 9GLOBAL GLUCOSE MONITORING MARKET REVENUE FORECAST, 20192025 ($MILLION)34
CHART 10GLOBAL INFECTIOUS DISEASE TESTING MARKET REVENUE FORECAST, 20192025 ($MILLION)35
CHART 11GLOBAL INFLUENZA TESTING MARKET REVENUE FORECAST, 20192025 ($MILLION)37
CHART 12GLOBAL HIV TESTING MARKET REVENUE FORECAST, 20192025 ($MILLION)39
CHART 13GLOBAL HEPATITIS TESTING MARKET REVENUE FORECAST, 20192025 ($MILLION)40
CHART 14GLOBAL TUBERCULOSIS TESTING MARKET REVENUE FORECAST, 20192025 ($MILLION)41
CHART 15GLOBAL SEXUALLY TRANSMITTED DISEASE TESTING MARKET REVENUE FORECAST, 20192025 ($MILLION)42
CHART 16GLOBAL HEALTHCARE-ASSOCIATED INFECTIONS TESTING MARKET REVENUE FORECAST, 20192025 ($MILLION)43
CHART 17GLOBAL RESPIRATORY INFECTIONS TESTING MARKET REVENUE FORECAST, 20192025 ($MILLION)44
CHART 18GLOBAL OTHERS MARKET REVENUE FORECAST, 20192025 ($MILLION)45
CHART 19GLOBAL PREGNANCY AND FERTILITY TESTING MARKET REVENUE FORECAST, 20192025 ($MILLION)46
CHART 20GLOBAL HEMATOLOGY TESTING MARKET REVENUE FORECAST, 20192025 ($MILLION)47
CHART 21GLOBAL CARDIOMETABOLIC MONITORING MARKET REVENUE FORECAST, 20192025 ($MILLION)48
CHART 22GLOBAL URINALYSIS TESTING MARKET REVENUE FORECAST, 20192025 ($MILLION)49
CHART 23GLOBAL COAGULATION MONITORING MARKET REVENUE FORECAST, 20192025 ($MILLION)51
CHART 24GLOBAL TUMOUR OR CANCER MARKER TESTING MARKET REVENUE FORECAST, 20192025 ($MILLION)52
CHART 25GLOBAL CHOLESTEROL TESTING MARKET REVENUE FORECAST, 20192025 ($MILLION)53
CHART 26GLOBAL DRUGS OF ABUSE TESTING MARKET REVENUE FORECAST, 20192025 ($MILLION)54
CHART 27GLOBAL OTHERS MARKET REVENUE FORECAST, 20192025 ($MILLION)55
CHART 28GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY PRESCRIPTION MODE, 2018 V/S 2025 (%)56
CHART 29GLOBAL PRESCRIPTION-BASED POINT-OF-CARE DIAGNOSTICS MARKET REVENUE FORECAST, 20192025 ($MILLION)57
CHART 30GLOBAL OTC-BASED POINT-OF-CARE DIAGNOSTICS MARKET REVENUE FORECAST, 20192025 ($MILLION)59
CHART 31GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY END-USERS SEGMENTATION, 2018 (%)60
CHART 32GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY GEOGRAPHICAL SEGMENTATION, 2018 V/S 2025 (%)63
CHART 33POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN NORTH AMERICA, 20192025 ($MILLION)64
CHART 34POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN EUROPE, 20192025 ($MILLION)66
CHART 35POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN UNITED KINGDOM, 20192025 ($MILLION)68
CHART 36POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN GERMANY, 20192025 ($MILLION)69
CHART 37POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN FRANCE, 20192025 ($MILLION)70
CHART 38POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN SPAIN, 20192025 ($MILLION)71
CHART 39POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN ITALY, 20192025 ($MILLION)72
CHART 40POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN OTHER EUROPEAN COUNTRIES, 20192025 ($MILLION)72
CHART 41POINT-OF-CARE DIAGNOSTICS REVENUE IN ASIA-PACIFIC, 20192025 ($MILLION)73
CHART 42POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN REST OF THE WORLD, 20192025 ($MILLION)76
CHART 43ABBOTT LABORATORIES.: OVERVIEW SNAPSHOT86
CHART 44ABBOTT LABORATORIES.: BUSINESS UNITS87
CHART 45ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE88
CHART 46ABBOTT LABORATORIES.: SWOT ANALYSIS88
CHART 51JOHNSON & JOHNSON: OVERVIEW SNAPSHOT100
CHART 52JOHNSON & JOHNSON: BUSINESS UNITS102
CHART 53JOHNSON & JOHNSON: GEOGRAPHIC REVENUE103
CHART 54JOHNSON & JOHNSON: SWOT ANALYSIS104
CHART 55DANAHER CORPORATION: OVERVIEW SNAPSHOT111
CHART 56DANAHER CORPORATION: BUSINESS UNITS112
CHART 57DANAHER CORPORATION: GEOGRAPHIC PRESENCE113
CHART 58DANAHER CORPORATION: SWOT ANALYSIS114
CHART 59SIEMENS HEALTHINEERS, INC.: OVERVIEW SNAPSHOT120
CHART 60SIEMENS HEALTHINEERS, INC.: BUSINESS UNITS121
CHART 61SIEMENS HEALTHINEERS: GEOGRAPHIC PRESENCE121
CHART 62SIEMENS HEALTHINEERS INC.: SWOT ANALYSIS122


US In Vitro Diagnostics Market for 500 Tests: Instrument and Reagent Supplier Shares, Volume and Sales Segment Forecasts, Business Environment, Market Structure

This new report provides an overview of the US diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales

USD 4500 View Report

UK In Vitro Diagnostics Market for 500 Tests: Instrument and Reagent Supplier Shares, Volume and Sales Segment Forecasts, Business Environment, Market Structure

This new report provides an overview of the UK diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales

USD 4500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available